Indefinite Delivery Contract HHSN261201000018I
- This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to the Sloan-Kettering Institute for Cancer Research, a non-profit organization located in New York, NY. The contract, valued at $200,000, supports the NCI's Cancer Genome Atlas (TCGA) program, which aims to collect and analyze tissue samples and data from various cancer types. The initial $120,500 task order under this contract requires the...
- This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Indivumed, Inc. to provide tissue samples and data from various types of cancer for the Cancer Genome Atlas (TCGA) program. The contract has a total ceiling value of $2,712,155.00 and does not have a set-aside designation. The contract consists of three firm-fixed-price delivery orders with a combined total value of $2,259,118.07. The...
- This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a civilian agency, to the Sloan-Kettering Institute for Cancer Research, a non-profit organization. The $550,000 single-award contract is part of the NCI Cancer Genome Atlas Program Tissue Purchase master contract and aims to procure tissue samples and data from various types of cancer for the Cancer Genome Atlas (TCGA) program. Under a $488,000 delivery order, Sloan-Kettering Institute for Cancer Research, a...
- This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI) to Mayo Clinic, a renowned non-profit academic medical center. The contract, valued at $130,403.07, supports the NCI's Cancer Genome Atlas (TCGA) program by recovering tissue samples and data from various types of cancer. It is part of a larger $9.9 million NCI Cancer Genome Atlas Program Tissue Purchase indefinite delivery/indefinite quantity (IDIQ) contract, which allows the NCI to efficiently...
- This Indefinite Delivery Contract (IDC) was awarded by the National Cancer Institute (NCI), a civilian agency, to the British Columbia Cancer Agency Branch, a Canadian non-profit organization, to procure tissue samples and data from various cancer types to support the NCI's Cancer Genome Atlas (TCGA) program. The $16,000 firm fixed-price delivery order was issued on September 20, 2010 under the NCI Cancer Genome Atlas Program Tissue Purchase contract, which does not have a set-aside designation....
- This Indefinite Delivery Contract (IDC) was awarded by the National Cancer Institute (NCI), a civilian agency, to Wielkopolskie Centrum Onkologii IM Marii Sklodowskiej Curie, also known as Centrum Onkologii, to provide tissue samples and data from various types of cancer for the Cancer Genome Atlas (TCGA) program. The contract, valued at $420,000, is a firm fixed price award and is not set aside for any special designation. It was issued under the NCI Cancer Genome Atlas Program Tissue...
- This is an Indefinite Delivery Contract (IDC) awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to the Sloan-Kettering Institute for Cancer Research, a non-profit organization. The contract, valued at up to $300,000, is part of the NCI Cancer Genome Atlas Program Tissue Purchase master contract vehicle. Under this contract, Sloan-Kettering Institute is required to provide tissue samples and data from various types of cancer for the...
- This Indefinite Delivery Contract (IDC) was awarded by the National Cancer Institute (NCI), part of the Department of Health and Human Services, to Augusta University Research Institute, Inc. (also known as Georgia Health Sciences) to provide tissue samples and data from various cancer types for the Cancer Genome Atlas (TCGA) program. The contract has a ceiling value of $87,500 and a period of performance through March 31, 2015. It is an ARRA-funded contract under the Recovery Act and does not...
- This is a single-award Indefinite Delivery Contract (IDC) issued by the National Cancer Institute (NCI), a civilian federal agency, to Cureline Inc., a woman-owned small business. The contract has a total ceiling value of $690,160.80 and is for the procurement of various human tissue samples to support the NCI Cancer Genome Atlas (TCGA) Program. The contract includes a firm fixed-price delivery order with a ceiling value of $212,610.63 for the purchase of breast ductal, colon, head and neck,...
- The National Cancer Institute (NCI) awarded an indefinite delivery/indefinite quantity (IDIQ) contract to The Johns Hopkins University to support the Cancer Genome Atlas (TCGA) program, which was funded under the American Recovery and Reinvestment Act (ARRA). The $159,600 multiple-award IDIQ contract, with a period of performance through March 2015, allows NCI to issue task orders for the acquisition of tissue samples and data from various cancer types for the TCGA program. A $129,675 firm...
- HHSN261201000018IIndefinite Delivery Contract
- 1Federal Contract Awards
This is a firm fixed-price delivery order awarded by the National Cancer Institute (NCI) to The GOG Foundation, Inc., a non-profit organization that provides administrative and operational support for cancer research programs. The $123,496.76 contract is part of the NCI Cancer Genome Atlas Program and involves the collection of tissue samples and data from various types of cancer to support the Cancer Genome Atlas (TCGA) program. The GOG Foundation, Inc. will likely leverage its expertise in grant management, regulatory compliance, data management, and operational support for multi-site cancer research studies to execute this contract in support of the TCGA program. The contract is a single-award indefinite delivery contract with a total ceiling value of $458,970.20. It is not set aside for any specific business category. The period of performance runs through September 30, 2014. The contract aims to procure in vitro diagnostic substances and reagents to support the NCI Cancer Genome Atlas Program's tissue sample and data collection efforts across various cancer types.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 4 | Other Administrative Action | $0 | 9/27/13 | |
| 3 | Other Administrative Action | $0 | 3/21/12 | |
| 2 | Other Administrative Action | $0 | 10/31/11 | |
| 1 | Supplemental Agreement for work within scope | $0 | 9/9/10 | |
| Not listed | Not listed | $0 | 3/15/10 |
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
Delivery Order HHSN261201000018I-HHSN26100001 | The GOG Foundation. Inc. | $123.5k | 3/22/10 | 9/30/14 | 2/4/15 |
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
RECOVERY: Tissue Purchase Order Contract Acquisition for NCI's The Cancer Genome Atlas Program | RFQ-NCI-10007-AS | Department of Health and Human Services National Institutes of Health | Award Notice 1/1 | 12/4/09, 8:15 AM |